Elutia Inc. Class A Common Stock (ELUT) is a publicly traded Healthcare sector company. As of October 22, 2026, ELUT trades at $0.86 with a market cap of $36.44M and a P/E ratio of 0.61. ELUT moved +0.00% today. Year to date, ELUT is +27.92%; over the trailing twelve months it is -8.17%. Its 52-week range spans $0.50 to $3.46. Analyst consensus is buy with an average price target of $5.00. Rallies surfaces ELUT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for ELUT, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $0.86 |
| Market Cap | $36.44M |
| P/E Ratio | 0.61 |
| EPS | $1.29 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.46 |
| 52-Week Low | $0.50 |
| Volume | 52.52K |
| Avg Volume | 0 |
| Revenue (TTM) | $12.29M |
| Net Income | $53.38M |
| Gross Margin | 53.66% |
1 analysts cover ELUT: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.00.